Medtronic plc (LON:0Y6X)

London flag London · Delayed Price · Currency is GBP · Price in USD
84.07
+0.81 (0.97%)
At close: May 8, 2025
2.98%
Market Cap 80.52B
Revenue (ttm) 26.58B
Net Income (ttm) 3.41B
Shares Out n/a
EPS (ttm) 2.62
PE Ratio 23.61
Forward PE 14.53
Dividend 2.17 (2.59%)
Ex-Dividend Date Mar 28, 2025
Volume 3,007
Average Volume 7,317
Open 83.89
Previous Close 83.26
Day's Range 83.39 - 84.47
52-Week Range 68.87 - 91.91
Beta 0.83
RSI 46.23
Earnings Date May 21, 2025

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1949
Employees 95,000
Stock Exchange London Stock Exchange
Ticker Symbol 0Y6X
Full Company Profile

Financial Performance

In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.

Financial numbers in USD Financial Statements

News

Medtronic to announce financial results for its fourth quarter and full fiscal year 2025

GALWAY, Ireland , May 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full...

5 days ago - PRNewsWire

New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women

Star Jones, award winning television personality & women's heart health advocate, helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign GALWAY, ...

5 days ago - PRNewsWire

Orchestra BioMed's AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure

Secured ten new fully-issued patents related to hypertension treatment during last 12 months, bringing global issued patent estate total for this condition to 120 patents Patent estate covering atriov...

5 days ago - Benzinga

Smart Pills Market Industry Trend Analysis, and Forecast 2025-2034, with Profiles of ANX Robotica, Bodycap, CapsoVision, Check-Cap, etectRx, Intromedic, Medtronic, Otsuka, Olympus and RF

Key growth drivers include the rise of gastrointestinal disorders and demand for non-invasive diagnostics. Smart pills, equipped with sensors and AI, facilitate real-time monitoring and personalized m...

12 days ago - GlobeNewsWire

Best Dividend Aristocrats For May 2025

Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Ed...

13 days ago - Seeking Alpha

Medtronic (MDT) Showcases Positive AFib Treatment Results at Key Medical Conference | MDT Stock News

Medtronic (MDT) Showcases Positive AFib Treatment Results at Key Medical Conference | MDT Stock News

15 days ago - GuruFocus

Medtronic PLC (MDT) Unveils Promising Clinical Trial Results for Atrial Fibrillation ...

Medtronic PLC (MDT) Unveils Promising Clinical Trial Results for Atrial Fibrillation Technologies | MDT stock news

16 days ago - GuruFocus

Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energy ...

16 days ago - PRNewsWire

Medtronic (MDT) Seeks FDA Approval for Hugo Robotic Surgery System

Medtronic (MDT) Seeks FDA Approval for Hugo Robotic Surgery System

16 days ago - GuruFocus

Medtronic PLC (MDT) Achieves Key Milestone with Hugo RAS System in U.S. ...

Medtronic PLC (MDT) Achieves Key Milestone with Hugo RAS System in U.S. Clinical Trial | MDT stock news

16 days ago - GuruFocus

Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for ...

Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system | MDT Stock News

16 days ago - GuruFocus

Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system

Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Associat...

16 days ago - PRNewsWire

Medtronic (MDT) Gains FDA Approval for Advanced Defibrillation Lead | MDT Stock News

Medtronic (MDT) Gains FDA Approval for Advanced Defibrillation Lead | MDT Stock News

17 days ago - GuruFocus

Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the ...

Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results | MDT Stock News

17 days ago - GuruFocus

Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025: Late-b...

17 days ago - PRNewsWire

Medtronic seeks FDA nod for insulin pump developed with Abbott

Medtronic (MDT) stock gains as the company seek FDA clearance for an insulin pump exclusively integrating CGM technology developed by Abbott (ABT). Read more here.

18 days ago - Seeking Alpha

Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump

GALWAY, Ireland , April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug Adm...

18 days ago - PRNewsWire

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

FDA recently granted Breakthrough Device Designation to AVIM therapy for use in patients with uncontrolled hypertension at increased cardiovascular risk HRS Satellite Symposium will feature leading ex...

19 days ago - GlobeNewsWire

Medtronic: One Of The Best Times To Buy

Medtronic offers a compelling long-term investment opportunity with solid revenue and earnings growth, driven by innovation in key segments. Read more about MDT stock here.

21 days ago - Seeking Alpha

Medtronic PLC (MDT) Receives FDA Approval for Simplera Sync™ Sensor | MDT stock news

Medtronic PLC (MDT) Receives FDA Approval for Simplera Sync™ Sensor | MDT stock news

24 days ago - GuruFocus

New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland , April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U....

24 days ago - PRNewsWire

Buy these stocks that are likely to beat earnings estimates, per Piper Sandler

Medtronic and Ross Stores are among the companies that are likely to beat estimates, according to the firm.

26 days ago - CNBC

The Best Large-Cap Stocks to Buy

Large-cap stocks are key additions to any well-rounded portfolio, but how do you find the best ones? We take a closer look here.

5 weeks ago - Kiplinger